Ethylene glycol monoethyl ether


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
10000 AKT3 Increases expression PMID:19643169
10388 SYCP2 Decreases expression PMID:19643169
1054 CEBPG Increases expression PMID:19643169
1056 CEL Increases expression PMID:19643169
10959 TMED2 Increases expression PMID:19643169
11261 CHP1 Increases expression PMID:19643169
1213 CLTC Increases expression PMID:19643169
1386 ATF2 Increases expression PMID:19643169
1452 CSNK1A1 Increases expression PMID:19643169
1453 CSNK1D Increases expression PMID:19643169
1456 CSNK1G3 Increases expression PMID:19643169
150094 SIK1 Increases expression PMID:19643169
1717 DHCR7 Increases expression PMID:19643169
2017 CTTN Increases expression PMID:19643169
2026 ENO2 Increases expression PMID:19643169
2054 STX2 Increases expression PMID:19643169
208 AKT2 Increases expression PMID:19643169
22905 EPN2 Increases expression PMID:19643169
23541 SEC14L2 Increases expression PMID:19643169
25833 POU2F3 Increases expression PMID:19643169
2626 GATA4 Increases expression PMID:19643169
2627 GATA6 Increases expression PMID:19643169
2665 GDI2 Increases expression PMID:19643169
3098 HK1 Increases expression PMID:19643169
3099 HK2 Increases expression PMID:19643169
3481 IGF2 Increases expression PMID:19643169
351 APP Increases expression PMID:19643169
3717 JAK2 Increases expression PMID:19643169
377 ARF3 Increases expression PMID:19643169
4067 LYN Increases expression PMID:19643169
42881 CAV Increases expression PMID:19643169
4601 MXI1 Increases expression PMID:19643169
4664 NAB1 Increases expression PMID:19643169
4774 NFIA Increases expression PMID:19643169
50511 SYCP3 Decreases expression PMID:19643169
5062 PAK2 Increases expression PMID:19643169
51143 DYNC1LI1 Decreases expression PMID:19643169
5208 PFKFB2 Increases expression PMID:19643169
5321 PLA2G4A Increases expression PMID:19643169
5331 PLCB3 Increases expression PMID:19643169
54861 SNRK Increases expression PMID:19643169
5576 PRKAR2A Increases expression PMID:19643169
5594 MAPK1 Increases expression PMID:19643169
5602 MAPK10 Increases expression PMID:19643169
56707 ZFP111 Increases expression PMID:19643169
5868 RAB5A Increases expression PMID:19643169
598 BCL2L1 Increases expression PMID:19643169
6047 RNF4 Increases expression PMID:19643169
6098 ROS1 Increases expression PMID:19643169
64089 SNX16 Increases expression PMID:19643169
6646 SOAT1 Increases expression PMID:19643169
6812 STXBP1 Increases expression PMID:19643169
6847 SYCP1 Decreases expression PMID:19643169
6924 ELOA Increases expression PMID:19643169
7026 NR2F2 Increases expression PMID:19643169
7091 TLE4 Increases expression PMID:19643169
7490 WT1 Increases expression PMID:19643169
7528 YY1 Increases expression PMID:19643169
7786 MAP3K12 Decreases expression PMID:19643169
7917 BAG6 Increases expression PMID:19643169
847 CAT Decreases activity PMID:20172899
9262 STK17B Increases expression PMID:19643169
DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.